OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Journal is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
PET Imaging of Metabolism, Perfusion, and Hypoxia	63
Social Drivers of Cancer Risk and Outcomes Among African American Men	43
Oncology Physician Workforce Diversity	34
Toxicities From Antibody-Drug Conjugates	20
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	19
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	19
Individualizing Therapy for Malignant Gliomas	17
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go	15
Building a Bridge to Equity in Health and Health Care in Cancer Care	15
Clinical Evidence Generation During a Pandemic	15
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	14
Nonoperative Management for Rectal Cancer	14
Health Care Policy and Disparities in Health	14
Stereotactic Body Radiation Therapy	14
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	13
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies	12
The Principles and Practice of PARP Inhibitor Therapy	12
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	11
Clinical Targeting of Altered Metabolism in High-Grade Glioma	11
Melanoma—Modern Treatment for Metastatic Melanoma	11
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	11
Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy	11
Metastatic Melanoma Treatment in Special Populations	10
Primary Prevention of Cancer	10
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	10

Diversity in Cancer Care	9
Antibody Drug Conjugates in Multiple Myeloma	9
Germline Predisposition to Myelodysplastic Syndromes	9
Prostate Cancer, Race, and Health Disparity	9
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	8
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	8
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	7
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	7
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	7
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	7
How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	7
DNA Damage Repair Inhibitors—Combination Therapies	7
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	7
Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas	7
Rectal Cancer—The Only Constant Is Change	7
Updates in the Management of Uveal Melanoma	7
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	6
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	6
Neurosurgical Advances for Malignant Gliomas	6
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	6
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	6
Menopausal Hormone Therapy and Breast Cancer	6
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	6
Impact of Precision Medicine in Oncology	6
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	6
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	6
Supportive Care for Patients With Myelodysplastic Syndromes	6
New Metabolomic Insights Into Cancer	6
Role of the Microbiome in Immunotherapy of Melanoma	6
How Far We’ve Come	6
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	6
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	5
Hormone Replacement Therapy After Breast Cancer	5
The Challenges and Future of Immunotherapy for Gliomas	5
Current State of Cell Therapies for Genitourinary Malignancies	5
Estrogen for the Treatment and Prevention of Breast Cancer	5
Telehealth and Technology	5
Telemedicine Across the Cancer Care Continuum	5
Survival of the Fittest	5
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	5
Introduction	5
Discovery of Natural Products for Cancer Prevention	5
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	5
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	5
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	5